185 related articles for article (PubMed ID: 7817485)
1. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.
Pienta KJ; Demers R; Hoff M; Kau TY; Montie JE; Severson RK
Urology; 1995 Jan; 45(1):93-101; discussion 101-2. PubMed ID: 7817485
[TBL] [Abstract][Full Text] [Related]
2. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
3. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States).
Barnholtz-Sloan JS; Severson RK; Vaishampayan U; Hussain M
Cancer Causes Control; 2003 Sep; 14(7):681-5. PubMed ID: 14575366
[TBL] [Abstract][Full Text] [Related]
5. Black-white differences in survival from late-stage prostate cancer.
Polednak AP
Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in cervical cancer survival in the Detroit metropolitan area.
Movva S; Noone AM; Banerjee M; Patel DA; Schwartz K; Yee CL; Simon MS
Cancer; 2008 Mar; 112(6):1264-71. PubMed ID: 18257090
[TBL] [Abstract][Full Text] [Related]
7. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
8. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.
Powell IJ; Dey J; Dudley A; Pontes JE; Cher ML; Sakr W; Grignon DJ; Wood DP
Urology; 2002 Jun; 59(6):907-12. PubMed ID: 12031379
[TBL] [Abstract][Full Text] [Related]
9. Race, prostate cancer survival, and membership in a large health maintenance organization.
Robbins AS; Whittemore AS; Van Den Eeden SK
J Natl Cancer Inst; 1998 Jul; 90(13):986-90. PubMed ID: 9665146
[TBL] [Abstract][Full Text] [Related]
10. Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.
Gadgeel SM; Severson RK; Kau Y; Graff J; Weiss LK; Kalemkerian GP
Chest; 2001 Jul; 120(1):55-63. PubMed ID: 11451816
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis.
Freeman VL; Durazo-Arvizu R; Keys LC; Johnson MP; Schafernak K; Patel VK
Am J Public Health; 2004 May; 94(5):803-8. PubMed ID: 15117704
[TBL] [Abstract][Full Text] [Related]
12. Descriptive epidemiology of prostate cancer in metropolitan Detroit.
Taylor JD; Holmes TM; Swanson GM
Cancer; 1994 Mar; 73(6):1704-7. PubMed ID: 8156498
[TBL] [Abstract][Full Text] [Related]
13. Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer.
Thatai LC; Banerjee M; Lai Z; Vaishampayan U
Urology; 2004 Oct; 64(4):738-43. PubMed ID: 15491712
[TBL] [Abstract][Full Text] [Related]
14. Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer.
Schwartz K; Powell IJ; Underwood W; George J; Yee C; Banerjee M
Urology; 2009 Dec; 74(6):1296-302. PubMed ID: 19962532
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
Zagars GK; Pollack A; Pettaway CA
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
[TBL] [Abstract][Full Text] [Related]
16. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
Culp SH; Schellhammer PF; Williams MB
Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
[TBL] [Abstract][Full Text] [Related]
17. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
20. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation.
Austin JP; Convery K
Am J Clin Oncol; 1993 Apr; 16(2):140-5. PubMed ID: 8452106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
